Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural changes in the actomyosin cross-bridges associated with force generation

B Brenner1, L C Yu

  • 1Department of General Physiology, University of Ulm, Germany.

Proceedings of the National Academy of Sciences of the United States of America
|June 1, 1993
PubMed
Summary

Muscle force generation involves distinct structural states of actomyosin cross-bridges. This study reveals that attached cross-bridges change structure during force generation, differing from preforce states.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Adjuvant immunotherapy in patients with resected gastric and oesophagogastric junction cancer following preoperative chemotherapy with high risk for recurrence (ypN+ and/or R1): European Organisation of Research and Treatment of Cancer (EORTC) 1707 VESTIGE study.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Treatments and clinical outcomes in stage II colon cancer patients with 12-gene Oncotype DX Colon Recurrence Score® assay-guided therapy: real-world data.

ESMO open·2024
Same author

Recommendations for the diagnosis and management of vaccine-induced immune thrombotic thrombocytopenia.

South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2021
Same author

Could arterial atherosclerosis herald cancer diagnosis?

Journal de medecine vasculaire·2021
Same author

Cisplatin and 5-fluorouracil with or without epidermal growth factor receptor inhibition panitumumab for patients with non-resectable, advanced or metastatic oesophageal squamous cell cancer: a prospective, open-label, randomised phase III AIO/EORTC trial (POWER).

Annals of oncology : official journal of the European Society for Medical Oncology·2020
Same author

Hypertrophic cardiomyopathy <i>MYH7</i> mutation R723G alters mRNA secondary structure.

Physiological genomics·2019

Area of Science:

  • Muscle physiology
  • Biophysics
  • Structural biology

Background:

  • Muscle contraction relies on myosin cross-bridges interacting with actin.
  • Evidence for conformational changes in attached cross-bridges during force generation remains debated.
  • Weakly attached cross-bridges in relaxed muscle may represent preforce states.

Purpose of the Study:

  • To investigate structural differences between attached cross-bridges in preforce and force-generating states.
  • To compare high-resolution x-ray diffraction patterns under relaxing and activating conditions.

Main Methods:

  • Utilized equatorial x-ray diffraction to analyze muscle cross-bridge structures.
  • Compared diffraction patterns from relaxed and activated muscle states with large fractions of attached cross-bridges.

Related Experiment Videos

  • Focused on changes in the innermost x-ray reflection intensities (I10 and I11).
  • Main Results:

    • Activation caused I10 intensity to decrease by 34% with minimal change in I11.
    • Observed changes in higher-order reflections alongside I10 and I11 alterations.
    • The pattern of intensity changes differed from expected reciprocal changes.

    Conclusions:

    • The structure of force-generating cross-bridges is distinct from weakly bound, preforce cross-bridges.
    • Actomyosin cross-bridge structure likely transitions between distinct states during force generation.
    • Findings support a model where force production involves structural state transitions in actomyosin cross-bridges.